Project: Development of BOT501, a Non-invasive Imaging Diagnostic for Fibrosis
| Acronym | BONIFIB (Reference Number: 11549) |
| Duration | 01/10/2017 |
| Project Topic | This project will deliver a first-in-class imaging agent (BOT501) for non-invasive diagnosis and monitoring of fibrosis. Here, the preclinical development of a peptide-based radio-labeled imaging agent will be finalized and a first-in-man study with liver fibrosis patients will be performed to establish clinical Proof of Concept. This project will deliver a novel tool for personalized and quantitative diagnosis, staging and risk stratification of fibrosis patients. |
| Network | Eurostars 2 |
| Call | Eurostars Cut-Off 7 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | BiOrion Technologies BV | Coordinator | Netherlands |
| 2 | Zealand Pharma A/S | Partner | Denmark |
| 3 | Akademiska sjukhuset | Partner | Sweden |